Tag: Prescription Drugs
Lowest Glucose Variability for Insulin + GLP-1 RA in T2DM
Lowest glucose variability, hypoglycemia for basal insulin + GLP-1 receptor agonist regimen
Long-Term DPP4-Inhibitor Use Not Tied to Fracture Risk in T2DM
No increase in risk of any fracture, osteoporotic or hip fractures with continuous long-term use
DEA Announces Critical Changes in Registration Renewal Process
The ability to renew a registration online after the expiration date will no longer be available
Imiquimod Has Sustained Benefit for Basal Cell Carcinoma
Lower treatment success for imiquimod 5 percent than surgery, but rates similar at three, five years
AARP: Medication Costs for Seniors Continue to Soar
Cost of brand-name drugs for chronic conditions rose nearly 130 times faster than inflation rate
Outcomes-Based Pricing Suggested for New, Costly Drugs
Strategy would compel manufacturers and insurers to share accountability for clinical outcomes
β-Blockers May Not Be Appropriate for Dementia Patients
In this group, use of drugs after acute myocardial infarction can compromise quality of life
Rate of Psychiatric Drug Use About 16 Percent in U.S. Adults
Highest rate of use seen for antidepressants
SABCS: Rx Combo Promising in Advanced HR+, HER2− Breast CA
Everolimus added to fulvestrant appears to improve progression-free survival
SABCS: Tamoxifen May Be Unfairly Blamed for Side Effects
Perceived side effects might lead some to stop taking the medication, researchers say
